Prediction of significant prostate cancer in biopsy-naïve men: Validation of a novel risk model combining MRI and clinical parameters and comparison to an ERSPC risk calculator and PI-RADS

BACKGROUND: Risk models (RM) need external validation to assess their value beyond the setting in which they were developed. We validated a RM combining mpMRI and clinical parameters for the probability of harboring significant prostate cancer (sPC, Gleason Score ≥ 3+4) for biopsy-naïve men. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Radtke, Jan Philipp, Giganti, Francesco, Wiesenfarth, Manuel, Stabile, Armando, Marenco, Jose, Orczyk, Clement, Kasivisvanathan, Veeru, Nyarangi-Dix, Joanne Nyaboe, Schütz, Viktoria, Dieffenbacher, Svenja, Görtz, Magdalena, Stenzinger, Albrecht, Roth, Wilfried, Freeman, Alex, Punwani, Shonit, Bonekamp, David, Schlemmer, Heinz-Peter, Hohenfellner, Markus, Emberton, Mark, Moore, Caroline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710031/
https://www.ncbi.nlm.nih.gov/pubmed/31450235
http://dx.doi.org/10.1371/journal.pone.0221350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710031/
https://www.ncbi.nlm.nih.gov/pubmed/31450235
http://dx.doi.org/10.1371/journal.pone.0221350

Ejemplares similares